Search research articles
Contact Us
Filters
Showing results (31-40 of 85) with videos related to
Page
of 9
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
April 23, 2019
Predictive factors of anemia during sofosbuvir and ribavirin therapy for genotype 2 chronic hepatitis C patients
Ayako Urabe, Ryotaro Sakamori, Yuki Tahata, et al.
Anticancer Research
|
April 4, 2021
Efficacy of Ramucirumab <i>Versus</i> Sorafenib as Subsequent Treatment for Hepatocellular Carcinoma
Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
December 17, 2021
Hyperprogressive disease in patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy
Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, et al.
Plos One
|
July 7, 2022
Serum amyloid P component and pro-platelet basic protein in extracellular vesicles or serum are novel markers of liver fibrosis in chronic hepatitis C patients
Kumiko Shirai, Hayato Hikita, Sadatsugu Sakane, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
July 25, 2021
White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in Mice
Sadatsugu Sakane, Hayato Hikita, Kumiko Shirai, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
June 7, 2017
Frequency of, and factors associated with, hepatitis B virus reactivation in hepatitis C patients treated with all-oral direct-acting antivirals: Analysis of a Japanese prospective cohort
Akira Doi, Ryotaro Sakamori, Yuki Tahata, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
November 21, 2019
Hepatocellular carcinoma occurrence does not differ between interferon-based and interferon-free treatment with liver histological assessment
Yuki Tahata, Ryotaro Sakamori, Ayako Urabe, et al.
Hepatology Communications
|
September 24, 2021
Capsid Allosteric Modulators Enhance the Innate Immune Response in Hepatitis B Virus-Infected Hepatocytes During Interferon Administration
Keisuke Fukutomi, Hayato Hikita, Kazuhiro Murai, et al.
The Journal of Veterinary Medical Science
|
August 13, 2024
Investigation of the mutations in the genes involved in Janus kinase/signal transducer and activator of transcription pathway in canine large cell gastrointestinal lymphoma
Takumi Tsuruta, Naoki Matsumura, Keijiro Mizukami, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
April 13, 2022
Comparison of atezolizumab plus bevacizumab and lenvatinib in terms of efficacy and safety as primary systemic chemotherapy for hepatocellular carcinoma
Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 85) with videos related to
Sort By:
Page
of 9
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
April 23, 2019
Predictive factors of anemia during sofosbuvir and ribavirin therapy for genotype 2 chronic hepatitis C patients
Ayako Urabe, Ryotaro Sakamori, Yuki Tahata, et al.
Anticancer Research
|
April 4, 2021
Efficacy of Ramucirumab <i>Versus</i> Sorafenib as Subsequent Treatment for Hepatocellular Carcinoma
Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
December 17, 2021
Hyperprogressive disease in patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy
Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, et al.
Plos One
|
July 7, 2022
Serum amyloid P component and pro-platelet basic protein in extracellular vesicles or serum are novel markers of liver fibrosis in chronic hepatitis C patients
Kumiko Shirai, Hayato Hikita, Sadatsugu Sakane, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
July 25, 2021
White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in Mice
Sadatsugu Sakane, Hayato Hikita, Kumiko Shirai, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
June 7, 2017
Frequency of, and factors associated with, hepatitis B virus reactivation in hepatitis C patients treated with all-oral direct-acting antivirals: Analysis of a Japanese prospective cohort
Akira Doi, Ryotaro Sakamori, Yuki Tahata, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
November 21, 2019
Hepatocellular carcinoma occurrence does not differ between interferon-based and interferon-free treatment with liver histological assessment
Yuki Tahata, Ryotaro Sakamori, Ayako Urabe, et al.
Hepatology Communications
|
September 24, 2021
Capsid Allosteric Modulators Enhance the Innate Immune Response in Hepatitis B Virus-Infected Hepatocytes During Interferon Administration
Keisuke Fukutomi, Hayato Hikita, Kazuhiro Murai, et al.
The Journal of Veterinary Medical Science
|
August 13, 2024
Investigation of the mutations in the genes involved in Janus kinase/signal transducer and activator of transcription pathway in canine large cell gastrointestinal lymphoma
Takumi Tsuruta, Naoki Matsumura, Keijiro Mizukami, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
April 13, 2022
Comparison of atezolizumab plus bevacizumab and lenvatinib in terms of efficacy and safety as primary systemic chemotherapy for hepatocellular carcinoma
Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, et al.
Page
of 9